Good, better, best. Never let it rest. 'Til your good is better and your better is best.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CETX @Cemtrex Announces Final Court Approval of the Settlements in the Securities Class Action & Shareholder Derivative Lawsuits
LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--
Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that the court has approved the previously announced settlements in the alleged securities class action lawsuit and related shareholder derivative litigations, filed in the Eastern District of New York and New York state court.
Under the class action settlement, the Company specifically denies any liability or that it has engaged in any wrongdoing. On behalf of the defendants, the Company’s insurer will pay $625,000 to the class of plaintiffs to resolve all claims asserted or could have been asserted in the litigation.
Under the derivative litigation settlement, the Company and the directors and officers of the Company named as defendants also deny any liability or wrongdoing in connection with the allegations contained in the lawsuit. The terms of the settlement require the Company to implement certain corporate governance changes and modify certain governance practices, and the Company’s insurer will pay $100,000 to the plaintiffs’ counsel. Like the class action settlement, the derivative litigation settlement resolves all claims that were or could have been asserted in the litigations.
“We are pleased to finally have the court approval of our settlement, and clear this cloud that has been hanging over us for the past two years,” said Saagar Govil, Cemtrex’s Chief Executive Officer, “This settlement has concluded these lawsuits expeditiously and further avoids interference on operations, which we believe is beneficial to the Company and its shareholders,” continued Mr. Govil.
The full settlement terms and all other filings in the class action litigation can be found under the case caption: Cullinan v. Cemtrex, Inc. et al., Case No. 2:17-cv-01067-JFB-AYS (E.D.N.Y.); the full settlement terms and all other filings in the derivative litigations are available under the following captions: Desmond-Newman v. Govil, et al., Case No. 2:18-cv-03992 (E.D.N.Y.), and Alami v. Govil, et al., No. 606635/2017 (N.Y. Sup. Ct., Suffolk County).
The Company is represented by Doug Greene, a nationally prominent securities litigation attorney, of the law firm of BakerHostetler.
About Cemtrex
Cemtrex, Inc. (CETX) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
https://finance.yahoo.com/news/cemtrex-announces-final-court-approval-123000861.html
"We are excited to be presenting our amazing new biometric card in association with ADVANTIS in Madrid on June 19 at the Secure Payments and ID Conference which is being attended by the leading banks in Europe. This will give us the opportunity to unveil our new biometric credit card that has been especially developed with the ADVANTIS credit card chip and payments system that is being used by 100 banks around the world," said today SmartMetric's President & CEO, Chaya Hendrick.
Chaya Hendrick, as a guest speaker at the conference, will be giving a presentation titled "BIOMETRIC CARD PAYMENTS: THE FUTURE IS NOW" on June 19, 2019 at 1:30pm.
Key Turning Points
DAILY 52-WEEK
2nd Resistance Point 0.0785
1st Resistance Point 0.0772
Last Price 0.0758
1st Support Level 0.0731
2nd Support Level 0.0703
$BTDG trades up Breakout watch ~
https://www.barchart.com/stocks/quotes/BTDG/cheat-sheet
$KOSK News Out " One Step Vending, Corp., Reveals Plans to Launch its Own Line of CBD Products
Harrison, New YorkJune 7th, 2019One Step Vending, Corp. (OTC Markets: KOSK) announces plans to launch its own line of CBD products as it is in discussions with premium American manufacturers to join their private label program.
The Company is currently developing a wholesale network with small business retailers and is placing third party products in affiliated stores. The plans to create its own line of products include edible products such as CBD Oil, for starters and more products will follow with the development of the brand. The products will be THC free and will carry all the necessary compliance certifications of the manufacturer and independent laboratories.
Were excited for our plan launching our own label products and we cant wait to finalize our discussions and details said Daniel Garfinkel, President of the Company.
More information on the course of plans and discussions will be revealed in future releases.
One Step Vending Corp. corporate website:http://www.onestepvending.com
Please follow us on twitter:https://twitter.com/onestepvend
About One Step Vending Corporation
One Step Vending Corp. is a holding company focused on the acquisition of market-changing and disruptive business models. The Company supports subsidiaries with key financial, sales, marketing, and operational changes designed to accelerate growth and shareholder value. For more information visit: http://www.onestepvending.com
About Sofos CBD Inc.
Sofos CBD Inc., a wholly owned subsidiary, is focusing on the wholesale and retail distribution of CBD infused products from American suppliers. The products include edibles such as tinctures, capsules, oils gummies and other products. The Company is developing a wholesale network with stores in order to supply CBD infused products for consumers and has formed strategic partnerships with certain suppliers to distribute their products. The Company is also aiming to sell retail CBD products through the use of vending machines, online and is currently developing an online platform that will be launched in the future.
https://www.otcmarkets.com/stock/KOSK/news/One-Step-Vending-Corp-Reveals-Plans-to-Launch-its-Own-Line-of-CBD-Products
$CETX @Cemtrex Announces Final Court Approval of the Settlements in the Securities Class Action & Shareholder Derivative Lawsuits
Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that the court has approved the previously announced settlements in the alleged securities class action lawsuit and related shareholder derivative litigations, filed in the Eastern District of New York and New York state court.
Under the class action settlement, the Company specifically denies any liability or that it has engaged in any wrongdoing. On behalf of the defendants, the Company’s insurer will pay $625,000 to the class of plaintiffs to resolve all claims asserted or could have been asserted in the litigation.
Under the derivative litigation settlement, the Company and the directors and officers of the Company named as defendants also deny any liability or wrongdoing in connection with the allegations contained in the lawsuit. The terms of the settlement require the Company to implement certain corporate governance changes and modify certain governance practices, and the Company’s insurer will pay $100,000 to the plaintiffs’ counsel. Like the class action settlement, the derivative litigation settlement resolves all claims that were or could have been asserted in the litigations.
“We are pleased to finally have the court approval of our settlement, and clear this cloud that has been hanging over us for the past two years,” said Saagar Govil, Cemtrex’s Chief Executive Officer, “This settlement has concluded these lawsuits expeditiously and further avoids interference on operations, which we believe is beneficial to the Company and its shareholders,” continued Mr. Govil.
The full settlement terms and all other filings in the class action litigation can be found under the case caption: Cullinan v. Cemtrex, Inc. et al., Case No. 2:17-cv-01067-JFB-AYS (E.D.N.Y.); the full settlement terms and all other filings in the derivative litigations are available under the following captions: Desmond-Newman v. Govil, et al., Case No. 2:18-cv-03992 (E.D.N.Y.), and Alami v. Govil, et al., No. 606635/2017 (N.Y. Sup. Ct., Suffolk County).
The Company is represented by Doug Greene, a nationally prominent securities litigation attorney, of the law firm of BakerHostetler.
About Cemtrex
Cemtrex, Inc. (CETX) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
https://ih.advfn.com/stock-market/NASDAQ/cemtrex-inc-CETX/stock-news/80058102/cemtrex-announces-final-court-approval-of-the-sett
$KOSK News - One Step Vending, Corp., Reveals Plans to Launch its Own Line of CBD Products
Harrison, New YorkJune 7th, 2019One Step Vending, Corp. (OTC Markets: KOSK) announces plans to launch its own line of CBD products as it is in discussions with premium American manufacturers to join their private label program.
The Company is currently developing a wholesale network with small business retailers and is placing third party products in affiliated stores. The plans to create its own line of products include edible products such as CBD Oil, for starters and more products will follow with the development of the brand. The products will be THC free and will carry all the necessary compliance certifications of the manufacturer and independent laboratories.
Were excited for our plan launching our own label products and we cant wait to finalize our discussions and details said Daniel Garfinkel, President of the Company.
More information on the course of plans and discussions will be revealed in future releases.
One Step Vending Corp. corporate website:http://www.onestepvending.com
Please follow us on twitter:https://twitter.com/onestepvend
About One Step Vending Corporation
One Step Vending Corp. is a holding company focused on the acquisition of market-changing and disruptive business models. The Company supports subsidiaries with key financial, sales, marketing, and operational changes designed to accelerate growth and shareholder value. For more information visit: http://www.onestepvending.com
About Sofos CBD Inc.
Sofos CBD Inc., a wholly owned subsidiary, is focusing on the wholesale and retail distribution of CBD infused products from American suppliers. The products include edibles such as tinctures, capsules, oils gummies and other products. The Company is developing a wholesale network with stores in order to supply CBD infused products for consumers and has formed strategic partnerships with certain suppliers to distribute their products. The Company is also aiming to sell retail CBD products through the use of vending machines, online and is currently developing an online platform that will be launched in the future.
https://www.otcmarkets.com/stock/KOSK/news/One-Step-Vending-Corp-Reveals-Plans-to-Launch-its-Own-Line-of-CBD-Products?id=230955
$OZSC OZOP SURGICAL MISSION
To economically disrupt the orthopedic and neurosurgical markets by providing premium quality surgical devices that result in immediate significant savings for providers, payers, and patients; and to continue to design and manufacture cutting-edge surgical solutions, with an emphasis on our innovations in the rapidly growing field of minimally invasive surgery.
http://ozopsurgical.com/
$OZSC Ozop Surgical Corp Announces Progress on New Spine Implant
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit
WEST PALM BEACH, FL / ACCESSWIRE / June 3, 2019 / Ozop Surgical Corp. (OTCQB:
OZSC), a provider of premium surgical devices in the rapidly growing field of
minimally invasive spine surgery, today announced significant development
progress and completion of initial testing of their novel adjustable ALIF
interbody spinal implant.
Michael Chermak, CEO, OZOP Surgical commented, "We are excited to have
completed initial testing for this novel device. Only through testing can we
learn how to create an optimal design and develop the instrumentation to allow
for an exceptional operative outcome for the surgeon and patient. Developing
an infinitely adjustable ALIF implant is a challenging design goal but the end
outcome will allow the surgeon to ensure segmental stability and restore
sagittal balance. We are encouraged by the results of this testing and have
incorporated several improvements into our next design. We look forward to
completing testing for FDA submission in the near future and hope to have our
approval by the end of the year".
About the OZOP Adjustable ALIF Implant
OZOP is developing an exciting new anterior spine implant that allows the
surgeon to expand it after insertion into the disc space. This allows for
patient specific adjustment, reduced operating time and inventory and cost
savings for the hospital. Instrumentation has been simplified and the locking
mechanism eliminates the cost and time needed for anterior supplemental
fixation.
About Ozop Surgical Corp.
Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops,
manufactures and distributes innovative endoscopic instruments, surgical
implants, instrumentation, devices and related technologies, focused on spine,
neurological and pain management procedures and specialties. Our focus is on
economically disrupting the market with clinically equivalent or superior
existing and new products resulting in immediate and significant savings for
providers, payors and consumers. For more information please visit
www.ozopsurgical.com.
$MFST Nice chart getting ready to go @Barchart
News " Medifirst Solutions Gets Approval For Merchant Account For Hemp And CBD Products
https://www.barchart.com/story/stocks/quotes/MFST/overview/2567475/medifirst-solutions-gets-approval-for-merchant-account-for-hemp-and-cbd-products …
$SMME SmartMetric brings the power of biometrics to the world of payments.
100% identity verification with secure transaction allows the consumer to safely purchase online or offline down the street.
Useable at ATM machines the SmartMetric biometric activated card has the added security of only being able to be used after you have activated it by using your fingerprint.
Simply touching the cards built in fingerprint reader and if it is you the card will work.
$MFST GlobeNewswire - Thu Jun 6 2019 @Medi_First Solutions Gets Approval For Merchant Account For Hemp And CBD Products
via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC:MFST) (the "Company" or "Medifirst"), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of USA Premium Hemp and CBD products, is pleased to provide an update.
Medifirst Solutions is pleased to announce that they have been approved for credit card processing for its USA CBD & Hemp products division. The CBD and Hemp products includes a 500mg oil, 1000mg oil and a premium 6000mg oil. In addition to the oils, also called tinctures, the company is selling CBD and Hemp Mints. Commented Medifirst President Bruce J. Schoengood, "We are very pleased with our initial development of CBD and Hemp products. The products under our USA line are of top premium quality and we believe our 6000mg oil presents a unique and potent product for consumers, especially those who suffer from more severe conditions. Our Premium Mints include twenty five 10mg mints in a sturdy tin. The Mints provide a great alternative to Hemp and CBD gummies which is a very popular consumer product. We believe that our Mints are better tasting and more potent than most gummy products on the market. Our goal is to have what we consider, the Gold Standard of CBD and Hemp products. "Products consumers you can trust" is our company mission."
Recent industry projections forecast the CBD market to hit 16 billion dollars by 2025. Continues Schoengood, "Although there appears to be many CBD products on the market, the industry is still in its infancy. We believe that adding high quality and some unique CBD and Hemp products to our product line is a great complement to our therapeutic Infrared Time Machine Laser used for helping people who suffer from pain and inflammation. The company anticipates an announcement in the coming days to officially launch and introduce the USA CBD and Hemp website and product line."
About the Time Machine Laser
The Time Machine Laser is the only all-in-one, affordable, FDA cleared, Infrared, 810nm, 2000mW power, small, hand-held portable laser marketed for pain relief in the U.S. The Time Machine Laser, which has been extensively tested and approved by Intertek for safety and electrical standards, has the power and frequency often found in large and expensive stationary units and at a fraction of the cost. Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for "The Time Machine" Series Laser, received clearance from the U.S. Food and Drug Administration ("FDA") to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Lasers is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Visit www.medifirstsolutions.com for more information. Follow on Twitter @Medi_First and for Facebook visit Medifirst Solutions.
Forward-Looking Statements:
The statements in this press release that relate to the company's expectations about the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.
Contact: Investor Relations
Phone: (732) 786-8044
Email: admin@medifirstsolutions.com
Website: www.medifirstsolutions.com
https://www.stocksreadytogo.com/2019/06/mfst-medifirst-solutions-gets-approval.html
$CETX On behalf of the defendants, the Company’s insurer will pay $625,000 to the class of plaintiffs to resolve all claims asserted or could have been asserted in the litigation.
Under the derivative litigation settlement, the Company and the directors and officers of the Company named as defendants also deny any liability or wrongdoing in connection with the allegations contained in the lawsuit. The terms of the settlement require the Company to implement certain corporate governance changes and modify certain governance practices, and the Company’s insurer will pay $100,000 to the plaintiffs’ counsel. Like the class action settlement, the derivative litigation settlement resolves all claims that were or could have been asserted in the litigations.
“We are pleased to finally have the court approval of our settlement, and clear this cloud that has been hanging over us for the past two years,” said Saagar Govil, Cemtrex’s Chief Executive Officer, “This settlement has concluded these lawsuits expeditiously and further avoids interference on operations, which we believe is beneficial to the Company and its shareholders,” continued Mr. Govil.
The full settlement terms and all other filings in the class action litigation can be found under the case caption: Cullinan v. Cemtrex, Inc. et al., Case No. 2:17-cv-01067-JFB-AYS (E.D.N.Y.); the full settlement terms and all other filings in the derivative litigations are available under the following captions: Desmond-Newman v. Govil, et al., Case No. 2:18-cv-03992 (E.D.N.Y.), and Alami v. Govil, et al., No. 606635/2017 (N.Y. Sup. Ct., Suffolk County).
The Company is represented by Doug Greene, a nationally prominent securities litigation attorney, of the law firm of BakerHostetler.
About Cemtrex
Cemtrex, Inc. (CETX) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
https://finance.yahoo.com/news/cemtrex-announces-final-court-approval-123000861.html
$SMME SmartMetric Inc ON ALERT ~ A presentation of the SmartMetric biometric credit card - Created and manufactured by SmartMetric, Inc. otcqb:smme
$SMME ON ALERT Secure Payments and ID Conference being held on June 19, 2019 in Madrid, Spain.
SmartMetric to Present the ADVANTIS SmartMetric Biometric Card at the Secure Payments and ID Conference in Madrid, Spain on June 19, 2019
Business Wire•May 29, 2019
NEW YORK--(BUSINESS WIRE)--
SmartMetric, Inc. (SMME) will be presenting its new biometric fingerprint activated credit card with the inbuilt ADVANTIS EMV Chip and banking operating system at the Secure Payments and ID Conference being held on June 19, 2019 in Madrid, Spain.
“We are excited to be presenting our amazing new biometric card in association with ADVANTIS in Madrid on June 19 at the Secure Payments and ID Conference which is being attended by the leading banks in Europe. This will give us the opportunity to unveil our new biometric credit card that has been especially developed with the ADVANTIS credit card chip and payments system that is being used by 100 banks around the world,” said today SmartMetric’s President & CEO, Chaya Hendrick.
Chaya Hendrick, as a guest speaker at the conference, will be giving a presentation titled “BIOMETRIC CARD PAYMENTS: THE FUTURE IS NOW” on June 19, 2019 at 1:30pm.
The conference will be attended by the leading banks in Europe along with the leading credit card manufacturers. The conference website is www.securepaymentsid.ifaes.com.
ADVANTIS is operating in 3 Continents in 40 Countries and its Chip and Operating system is being used on over 1.3 BILLION credit cards.
SMARTMETRIC is based in the USA with marketing and engineering in various parts of the World. SmartMetric has created a fingerprint scanner that fits inside a credit and debit card and is used to provide biometric protection for these cards. The card user simply touches a square sensor on the card's surface and in less than 0.25 seconds the card's internal fingerprint scanner reads the card user's fingerprint and if the fingerprint matches the card is immediately turned on.
With instant biometric validation and card activation means that the SmartMetric biometric card technology provides seamless use by the card customer. By the time the credit/debit card user reaches across to insert the card in a reader or ATM the card has been biometrically authenticated and turned on.
To view the SmartMetric Biometric Card please follow this link - Video of the Sm
DD LINK - https://www.stocksreadytogo.com/2019/06/smme-secure-payments-and-id-conference.html $GO $NICE $PLAY $HIT $GROW $SPOT
$SMME Secure Payments and ID Conference being held on June 19, 2019 in Madrid, Spain.
SmartMetric to Present the ADVANTIS SmartMetric Biometric Card at the Secure Payments and ID Conference in Madrid, Spain on June 19, 2019
Business Wire•May 29, 2019
NEW YORK--(BUSINESS WIRE)--
SmartMetric, Inc. (SMME) will be presenting its new biometric fingerprint activated credit card with the inbuilt ADVANTIS EMV Chip and banking operating system at the Secure Payments and ID Conference being held on June 19, 2019 in Madrid, Spain.
“We are excited to be presenting our amazing new biometric card in association with ADVANTIS in Madrid on June 19 at the Secure Payments and ID Conference which is being attended by the leading banks in Europe. This will give us the opportunity to unveil our new biometric credit card that has been especially developed with the ADVANTIS credit card chip and payments system that is being used by 100 banks around the world,” said today SmartMetric’s President & CEO, Chaya Hendrick.
Chaya Hendrick, as a guest speaker at the conference, will be giving a presentation titled “BIOMETRIC CARD PAYMENTS: THE FUTURE IS NOW” on June 19, 2019 at 1:30pm.
The conference will be attended by the leading banks in Europe along with the leading credit card manufacturers. The conference website is www.securepaymentsid.ifaes.com.
ADVANTIS is operating in 3 Continents in 40 Countries and its Chip and Operating system is being used on over 1.3 BILLION credit cards.
SMARTMETRIC is based in the USA with marketing and engineering in various parts of the World. SmartMetric has created a fingerprint scanner that fits inside a credit and debit card and is used to provide biometric protection for these cards. The card user simply touches a square sensor on the card's surface and in less than 0.25 seconds the card's internal fingerprint scanner reads the card user's fingerprint and if the fingerprint matches the card is immediately turned on.
With instant biometric validation and card activation means that the SmartMetric biometric card technology provides seamless use by the card customer. By the time the credit/debit card user reaches across to insert the card in a reader or ATM the card has been biometrically authenticated and turned on.
To view the SmartMetric Biometric Card please follow this link - Video of the Sm
DD LINK - https://www.stocksreadytogo.com/2019/06/smme-secure-payments-and-id-conference.html
$OZSC a provider of premium surgical devices in the rapidly growing field of minimally invasive spine surgery, today announced significant development progress and completion of initial testing of their novel adjustable ALIF interbody spinal implant.
Michael Chermak, CEO, OZOP Surgical commented, "We are excited to have completed initial testing for this novel device. Only through testing can we learn how to create an optimal design and develop the instrumentation to allow for an exceptional operative outcome for the surgeon and patient. Developing an infinitely adjustable ALIF implant is a challenging design goal but the end outcome will allow the surgeon to ensure segmental stability and restore sagittal balance. We are encouraged by the results of this testing and have incorporated several improvements into our next design. We look forward to completing testing for FDA submission in the near future and hope to have our approval by the end of the year".
About Ozop Surgical Corp.
Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops, manufactures and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information please visit www.ozopsurgical.com. $RUN $PLAY $GROW
$RGBP trades up Moving @ 0.0010+0.0001 (+11.11%) volume 1,745,650
Regen BioPharma, Inc. is a publicly traded biotechnology company (RGBP) and (RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
$SURG Surge Provides Update on Rollout of SurgePays Network and Announces 15% Increase in Revenue to $3.9 Million for the First Quarter of 2019
Announces initial placement order for SurgePhones and SIM Starter Kits valued at over $17.5 million
https://www.globenewswire.com/news-release/2019/05/16/1826154/0/en/Surge-Provides-Update-on-Rollout-of-SurgePays-Network-and-Announces-15-Increase-in-Revenue-to-3-9-Million-for-the-First-Quarter-of-2019.html
$SURG DAILY CHART https://stockcharts.com/h-sc/ui?s=SURG
MOVING DOWN TAKE ADVANTAGE YAAAAHOOOO
$CETX Cemtrex Announces Final Court Approval of the Settlements in the Securities Class Action & Shareholder Derivative Lawsuits
LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--
Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that the court has approved the previously announced settlements in the alleged securities class action lawsuit and related shareholder derivative litigations, filed in the Eastern District of New York and New York state court.
Under the class action settlement, the Company specifically denies any liability or that it has engaged in any wrongdoing. On behalf of the defendants, the Company’s insurer will pay $625,000 to the class of plaintiffs to resolve all claims asserted or could have been asserted in the litigation.
Under the derivative litigation settlement, the Company and the directors and officers of the Company named as defendants also deny any liability or wrongdoing in connection with the allegations contained in the lawsuit. The terms of the settlement require the Company to implement certain corporate governance changes and modify certain governance practices, and the Company’s insurer will pay $100,000 to the plaintiffs’ counsel. Like the class action settlement, the derivative litigation settlement resolves all claims that were or could have been asserted in the litigations.
“We are pleased to finally have the court approval of our settlement, and clear this cloud that has been hanging over us for the past two years,” said Saagar Govil, Cemtrex’s Chief Executive Officer, “This settlement has concluded these lawsuits expeditiously and further avoids interference on operations, which we believe is beneficial to the Company and its shareholders,” continued Mr. Govil.
The full settlement terms and all other filings in the class action litigation can be found under the case caption: Cullinan v. Cemtrex, Inc. et al., Case No. 2:17-cv-01067-JFB-AYS (E.D.N.Y.); the full settlement terms and all other filings in the derivative litigations are available under the following captions: Desmond-Newman v. Govil, et al., Case No. 2:18-cv-03992 (E.D.N.Y.), and Alami v. Govil, et al., No. 606635/2017 (N.Y. Sup. Ct., Suffolk County).
The Company is represented by Doug Greene, a nationally prominent securities litigation attorney, of the law firm of BakerHostetler.
About Cemtrex
Cemtrex, Inc. (CETX) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
$MFST News : Medifirst Solutions Gets Approval for Merchant Account for Hemp and CBD Products
https://www.nasdaq.com/press-release/medifirst-solutions-gets-approval-for-merchant-account-for-hemp-and-cbd-products-20190606-00511
$HIPH News Out : American Premium Water Corporation (OTC:HIPH) Announces Developed Prototype of CBD Pet Water With JV Partner LinkRes Pets
https://ih.advfn.com/stock-market/USOTC/american-premium-water-HIPH/stock-news/80079908/american-premium-water-corporation-otc-hiph-announ
GO BIG $CETX NICE MOVE !
DAILY CETX http://schrts.co/JyFDNbCq
GO BIG $CETX NICE MOVE !
DAILY CETX http://schrts.co/JyFDNbCq
$SMME GREAT NEWS INFO @ SmartMetric to Present the ADVANTIS SmartMetric Biometric Card at the Secure Payments and ID Conference in Madrid, Spain on June 19, 2019
NEW YORK--(BUSINESS WIRE)--
SmartMetric, Inc. (SMME) will be presenting its new biometric fingerprint activated credit card with the inbuilt ADVANTIS EMV Chip and banking operating system at the Secure Payments and ID Conference being held on June 19, 2019 in Madrid, Spain.
“We are excited to be presenting our amazing new biometric card in association with ADVANTIS in Madrid on June 19 at the Secure Payments and ID Conference which is being attended by the leading banks in Europe. This will give us the opportunity to unveil our new biometric credit card that has been especially developed with the ADVANTIS credit card chip and payments system that is being used by 100 banks around the world,” said today SmartMetric’s President & CEO, Chaya Hendrick.
Chaya Hendrick, as a guest speaker at the conference, will be giving a presentation titled “BIOMETRIC CARD PAYMENTS: THE FUTURE IS NOW” on June 19, 2019 at 1:30pm.
The conference will be attended by the leading banks in Europe along with the leading credit card manufacturers. The conference website is www.securepaymentsid.ifaes.com.
ADVANTIS is operating in 3 Continents in 40 Countries and its Chip and Operating system is being used on over 1.3 BILLION credit cards.
SMARTMETRIC is based in the USA with marketing and engineering in various parts of the World. SmartMetric has created a fingerprint scanner that fits inside a credit and debit card and is used to provide biometric protection for these cards. The card user simply touches a square sensor on the card's surface and in less than 0.25 seconds the card's internal fingerprint scanner reads the card user's fingerprint and if the fingerprint matches the card is immediately turned on.
With instant biometric validation and card activation means that the SmartMetric biometric card technology provides seamless use by the card customer. By the time the credit/debit card user reaches across to insert the card in a reader or ATM the card has been biometrically authenticated and turned on.
To view the SmartMetric Biometric Card please follow this link - Video of the SmartMetric Biometric Card. To view the company website: www.smartmetric.com.
$RGBP Fast Forwarding Checkpoint Medicine
Striving to improve the quality of life by introducing the latest in medical technology for treating cancer and autoimmunity
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6. The company also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate). $GROW $RUN
https://www.regenbiopharmainc.com/
$MFST LOADING ... Medifirst Solutions TECHNICAL CHART
https://www.barchart.com/stocks/quotes/MFST/interactive-chart
$RVIV - TECHNICAL CHART VIEW BLOW UP ANYTIME IMO
https://www.barchart.com/stocks/quotes/RVIV/technical-chart
$RVIV ON NEWS TODAY : Reviv3 Procare Announces Agreement With Hong Kong Distributor for Product Launch in JD.com
LOS ANGELES, California, June 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Reviv3 Procare Company (RVIV), a manufacturer of premium hair and skin care products, today announced it has expanded its distribution agreement with XJS Science Limited, a Hong Kong based Distribution Company with operations in Nanjing and Shanghai, China to market Reviv3 products on JD.com, China’s largest e-commerce company by revenue.
Commenting on this initiative, Jeff Toghraie, Reviv3’s CEO, stated, “As we continue to expand our brand awareness in the domestic and international markets, the China market is of particular interest and increased focus for REVIV3. Online sales in China has seen tremendous growth to about $1.33 trillion in 2018, an increase of 23.90% compared with 2017, according to the National Bureau of Statistics in China. Our Reviv3 Cleanse, Reviv3 Moisture+ Conditioner, Reviv3 Scalp Treatment and four additional hair products designed for healthy hair and scalp maintenance are currently registered and approved by the China Food & Drug Administration and we are very excited in our partnership with XJS Science to introduce these products to the China consumers via the JD.com online platform.”
About Reviv3 Procare Company
Reviv3 Procare Company is engaged in the manufacturing, marketing, sale and distribution of professional quality hair and skin care products under various trademarks and brands. We are committed to using the highest quality active ingredients found in nature to create professional grade products that simply work. Our products are sold in targeted markets in United States, Canada, Europe, and Asia.
https://finance.yahoo.com/news/reviv3-procare-announces-agreement-hong-130000186.html
$OZSC MORE ROOM TO GROW INTERACTIVE CHART https://www.barchart.com/stocks/quotes/OZSC/interactive-chart
Ozop Surgical Corp Announces Progress on New Spine Implant
ACCESSWIRE ACCESSWIRE•June 3, 2019
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit
WEST PALM BEACH, FL / ACCESSWIRE / June 3, 2019 / Ozop Surgical Corp. (OZSC), a provider of premium surgical devices in the rapidly growing field of minimally invasive spine surgery, today announced significant development progress and completion of initial testing of their novel adjustable ALIF interbody spinal implant.
Michael Chermak, CEO, OZOP Surgical commented, "We are excited to have completed initial testing for this novel device. Only through testing can we learn how to create an optimal design and develop the instrumentation to allow for an exceptional operative outcome for the surgeon and patient. Developing an infinitely adjustable ALIF implant is a challenging design goal but the end outcome will allow the surgeon to ensure segmental stability and restore sagittal balance. We are encouraged by the results of this testing and have incorporated several improvements into our next design. We look forward to completing testing for FDA submission in the near future and hope to have our approval by the end of the year".
About the OZOP Adjustable ALIF Implant
OZOP is developing an exciting new anterior spine implant that allows the surgeon to expand it after insertion into the disc space. This allows for patient specific adjustment, reduced operating time and inventory and cost savings for the hospital. Instrumentation has been simplified and the locking mechanism eliminates the cost and time needed for anterior supplemental fixation.
About Ozop Surgical Corp.
Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops, manufactures and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information please visit www.ozopsurgical.com.
$CETX NICE VIEW DAILY CHART https://stockcharts.com/h-sc/ui?s=CETX
Cemtrex Announces Final Court Approval of the Settlements in the Securities Class Action & Shareholder Derivative Lawsuits
Business Wire Business WireJune 4, 2019
LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--
Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that the court has approved the previously announced settlements in the alleged securities class action lawsuit and related shareholder derivative litigations, filed in the Eastern District of New York and New York state court.
Under the class action settlement, the Company specifically denies any liability or that it has engaged in any wrongdoing. On behalf of the defendants, the Company’s insurer will pay $625,000 to the class of plaintiffs to resolve all claims asserted or could have been asserted in the litigation.
Under the derivative litigation settlement, the Company and the directors and officers of the Company named as defendants also deny any liability or wrongdoing in connection with the allegations contained in the lawsuit. The terms of the settlement require the Company to implement certain corporate governance changes and modify certain governance practices, and the Company’s insurer will pay $100,000 to the plaintiffs’ counsel. Like the class action settlement, the derivative litigation settlement resolves all claims that were or could have been asserted in the litigations.
“We are pleased to finally have the court approval of our settlement, and clear this cloud that has been hanging over us for the past two years,” said Saagar Govil, Cemtrex’s Chief Executive Officer, “This settlement has concluded these lawsuits expeditiously and further avoids interference on operations, which we believe is beneficial to the Company and its shareholders,” continued Mr. Govil.
The full settlement terms and all other filings in the class action litigation can be found under the case caption: Cullinan v. Cemtrex, Inc. et al., Case No. 2:17-cv-01067-JFB-AYS (E.D.N.Y.); the full settlement terms and all other filings in the derivative litigations are available under the following captions: Desmond-Newman v. Govil, et al., Case No. 2:18-cv-03992 (E.D.N.Y.), and Alami v. Govil, et al., No. 606635/2017 (N.Y. Sup. Ct., Suffolk County).
The Company is represented by Doug Greene, a nationally prominent securities litigation attorney, of the law firm of BakerHostetler.
About Cemtrex
Cemtrex, Inc. (CETX) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
$SURG DAILY CHART https://stockcharts.com/h-sc/ui?s=SURG
Surge Provides Update on Rollout of SurgePays Network and Announces 15% Increase in Revenue to $3.9 Million for the First Quarter of 2019
GlobeNewswire•May 16, 2019
Announces initial placement order for SurgePhones and SIM Starter Kits valued at over $17.5 million
Memphis, TN, May 16, 2019 (GLOBE NEWSWIRE) -- Surge Holdings, Inc. (“Surge”) (SURG), developer of the SurgePays™ Network for independent retailers, today provided a business update and announced financial results for the first quarter ended March 31, 2019.
Brian Cox, CEO and Chairman of Surge Holdings, commented, “I am pleased to report we are making tremendous progress in the development and rollout of the SurgePays Network, which empowers independent retailers as profit partners to access products and services through our secure, blockchain-based technology platform. This system reinvents the retail supply chain by providing independent retailers seamless access to global products and the ability to select, order and fulfill delivery of wholesale goods from around the country. Our system also provides a cost-effective and efficient platform for regional manufacturers to access retailers nationwide.”
“Through our recently announced partnership with AATAC, one of the nation's largest private trade associations, we expect to rollout the SurgePays Network into nearly 40,000 independent retail stores within 9 months. We plan to leverage this massive distribution channel by introducing proprietary products such as our SurgePays Visa Card as well as our SurgePhone and SIM Starter Kit. Under our initial agreement with AATAC, the participating retailers will purchase a minimum of 6 Surge Android smartphones and 10 SurgePhone SIM Starter Kits per store. We estimate the minimum guaranteed value of the initial purchase order alone to be well in excess of $17.5 million. In addition, we anticipate a high replenishment rate based on market feedback and preferred in-store product placement utilizing our custom countertop displays. We will be introducing the SurgePays Visa Card in June, as well as other high margin products and services from other manufacturers.”
“I am also pleased to report that we achieved 15% growth in revenue to $3.9 million for the first quarter of 2019. Through our subsidiary True Wireless, we provide subsidized wireless service to low income individuals in 5 states limited to one phone per household. We are gradually transitioning towards our SurgePhone Wireless and SIM Starter Kit model, which offers the first completely free wireless service supported by ad revenue and available in all 50 states with no limits per household. We believe this represents an enormous, untapped and highly scalable market opportunity that is not dependent on government subsidies.”
“Most recently, we announced that we achieved another major milestone with the integration of UPS into the SurgePays fulfillment module, which is now live on the system. We believe this integration will streamline the process of ordering, fulfilling and delivering products. In addition, we can lower distribution costs for manufacturers by allowing them to leverage the mass purchasing power available through UPS on our network. We plan to begin onboarding manufacturers to the SurgePays network during the second quarter.”
“Finally, in March we announced that we filed an application to list on the NASDAQ Capital Market. If approved, we believe this listing will help broaden awareness of the company within the investment community as we continue to execute on our business model."
First Quarter 2019 Financial Highlights
For the three months ended March 31, 2019 and 2018, revenues were approximately $3.9 million and $3.4 million, respectively. Operating loss for the three months ended March 31, 2019 was approximately $(1.1) million versus operating income of approximately $0.4 million for the quarter ended March 31, 2018, reflecting increased expenses following the True Wireless merger and investment to build out the SurgePays Network. Net loss for the three months ended March 31, 2019 was approximately $(1.6) million, or $(0.02) per share, versus a net income of $0.4 million, or $0.01 per share, in the prior period.
A copy of the Company’s quarterly report on Form 10-Q has been filed with the Securities and Exchange Commission (www.sec.gov) and posted on the Company’s website at https://surgeholdings.com/.
$BTDG News Update Today : B2Digital (OTCMKTS: BTDG) B2 Fighting Series Acquires License to Expand and Hold MMA Fights in Tennessee
Tampa, FL, June 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- B2Digital, Incorporated (BTDG) (“B2Digital”) B2Digital, www.b2digitalotc.com, announced today that its HRMMA Fight Group has been officially licensed by the State of Tennessee Athletic Commission to hold and operate fights in Tennessee, www.hrmma.com.
The B2 Fighting Series, owned by B2Digital Inc., will expand its operation in 2019 to include holding LIVE Events in Tennessee.
HRMMA has held 108 Live Events in cities across Kentucky and Ohio including fights in Bowling Green, Kentucky, an hour drive from Nashville. The recent Bowling Green Fights drew fans from the Nashville area. This makes it a natural extension to expand into Tennessee for the B2 Fighting Series HRMMA Fight Group.
HRMMA CEO, Vanessa Higdon, will manage the expansion of the HRMMA Fight Group. The Company plans to start promoting immediately towards having its first fights in Tennessee in 2019. Brandon Higdon, the current matchmaker for HRMMA, will be the matchmaker. He will be working closely with fighters to match the fight cards for the upcoming events in Tennessee.
“This expansion is the ongoing plan to expand the B2 Fighting Series into more states and build off our expanding number of events and further develop our relationships with the fighters. We look forward to adding these new locations to our growing and expanding schedule of events,” said Brandon Higdon, HRMMA’s Matchmaker.
Vanessa Higdon, CEO of HRMMA, added, “After successfully completing over 100 shows in Kentucky, and our expansion into Ohio, I feel like we have room to grow the B2 Fighting Series. Tennessee has a solid base of MMA fans and we look forward to holding our first HRMMA B2 Fighting Series LIVE Events in Tennessee.”
“A lot of planning has gone into expanding and growing the B2 Fighting Series business and increasing the number of LIVE Events that we are holding each year that will fuel our revenue growth. We have LIVE Events planned to be held in Tennessee in 2019 and have additional expansion planned into other states for 2019 and 2020,” said Greg P. Bell, Chairman & CEO of B2Digital Inc.
In other company news and events, although the Company and BTDG management does not consider the following as newsworthy events, the Company and BTDG management is providing this update to its fans, followers and shareholders. The Company has filed its financial results of its operations for the FY 2018-2019 through Q3. The company is pursuing its aspirations towards becoming a fully reporting company; as it takes its first steps towards reaching that objective with the goal of up listing to higher-level tiers of trading with OTC markets and working on becoming a full SEC Reporting Company. The company continues to be encouraged with the operational performance of its LIVE Event companies and Events, along with the large audience it has created with the B2 Social Media Network “B2SN”. The Company continues to work on its strategy of improving current company operations, acquiring additional Sports related companies and Growing the current B2 Digital business.
The Company intends to release additional news and updates on a timely basis to its followers and shareholders.
About B2Digital, Incorporated
With extensive background in entertainment, television, video and technology, the Company is now forging ahead and becoming a full-service Live Event Sports Company. The Chairman and CEO of the company at the helm is Greg P. Bell. Capitalizing on the combination of his expertise, relationships and experience as well as his involvement with more than 40,000 LIVE events over his career for major sports leagues and entertainment venues, B2 Digital is in the process of developing and acquiring MMA and sports related companies to become a Premier Vertically Integrated LIVE Event Sports Company. B2's first strategy is to build an integrated Premier Development League for the MMA Mixed Martial Arts marketplace, which is a billion-dollar industry.
B2 Digital will be creating and developing Development League champions that will move on to the MMA Major Leagues from the B2 Fighting Series. In 2017 B2 started operating B2FS LIVE MMA Events and each year the top fighters will be invited to the yearly B2FS National Championship Live Event. B2 owns all rights for TV, Internet, Social Media, media, merchandising and trademarks and branding for the B2 Digital Companies. B2 has deployed its B2 Social Media Network digital distribution network for the B2 Fighting Series and has developed and deployed the Systems and Technologies for the operation of Social Media Marketing, Event Management, Digital Ticketing Sales, Digital Video Distribution, Digital Marketing, PPV, Fighter Management, Merchandise Sales, Brand Management and Financial Control Systems.
Link :
https://finance.yahoo.com/news/b2digital-otcmkts-btdg-b2-fighting-123000430.html
$NGTF Nightfood Ice Cream Announced as Multiple-Category Finalist in World Dairy Innovation Awards 2019
Tarrytown, NY, June 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nightfood, Inc. (NGTF), the innovative ice cream company solving America’s $50 billion-dollar nighttime snacking problem, today announced Nightfood has been named a finalist in the 2019 World Dairy Innovation Awards.
Nightfood was entered in four categories for the awards, and is a finalist in the following three categories: Best Dairy Dessert, Best Ice Cream, and Best Brand.
“This is amazing news for our brand,” exclaimed Nightfood CEO Sean Folkson. “Our goal is not necessarily to win awards, but winning, or being named a finalist, sends very clear signals to supermarket category managers about where the future of the category is going.”
The winners in all 22 categories will be announced as part of a special ceremony at Zenith Global’s Global Dairy Congress in Lisbon on June 26.
Nightfood Management recently announced that updated projections based on recent corporate developments call for revenues exceeding $3,000,000 in 2019 calendar Q4, and profitability in that same quarter.
In addition, Management is targeting distribution in 10,000 points of sale by March 31, 2019. Like the previously-announced 2019 Product of the Year award in the ice cream category in a Kantar survey of 40,000 consumers, Folkson believes this industry recognition supports the brand’s distribution initiatives.
About Nightfood Holdings:
Nightfood Holdings, Inc. (NGTF), owns Nightfood, Inc. and MJ Munchies, Inc.
On Feb 8, 2019, it was announced that Nightfood ice cream won the 2019 Product of the Year award in the ice cream category in a Kantar survey of over 40,000 consumers.
With the overwhelming majority of at-home ice cream consumption occurring in the hours before bed, Nightfood’s sleep-friendly nighttime ice cream, formulated by sleep and nutrition experts, delivers benefits found in no other product on the market.
Market research giant Mintel identified nighttime specific food and beverages as one of their most “compelling and category changing” trends for the coming years
Nightfood ice cream is rolling out nationally and has recently announced distribution in the popular Meijer supermarket chain throughout the Midwest, with concentration in the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus, and Milwaukee, as well as Lowes Foods, with 78 stores in the Carolinas and Virginia.
To enter the Nightfood® Ice Cream Giveaway, where the Company is giving away a one-year supply of Nightfood ice cream, plus a brand-new freezer to store it in, visit http://nightfood.com
MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the brand name “Half-Baked”, for which they’ve successfully secured trademark rights.
For more information, visit http://ir.Nightfood.com and http://Nightfood.com
Questions can be directed to investors@Nightfood.com
https://finance.yahoo.com/news/nightfood-ice-cream-announced-multiple-141143531.html
$HIPH News Today :Investor Ideas Potcasts - Live From New York: Interview with Ryan Fishoff, CEO of American Premium Water Corp.
Delta and Kelowna, British Columbia--(Newsfile Corp. - June 5, 2019) - www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM, with our interview with Ryan Fishoff, CEO of American Premium Water Corp. (OTC: HIPH), where we discussed the CBD sector in the US, as well as the UK and Europe, American Premium Water's latest deals and partnerships and the company's goals for 2019.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2019/060419-OTCHIPH-RyanFishoff.mp3
Ryan discussed American Premium Water Corporation's recent announcement of returning thirty (30) million common shares to treasury, which helped reduce the company's issued and outstanding share count.
"Everything that we're doing is with the intention of going to the NASDAQ. I laid out a number of goals in the beginning of the year in a letter to our shareholders, and one of those goals was to retire shares and we've been successful in doing that, and we're not stopping with this particular block. We're exploring other avenues to retire more shares in the near and long term future."
When asked about the company's timeline for the NASDAQ, Ryan was confident in saying the company's goal is "the end of 2020 to get to the NASDAQ".
Ryan also discussed the company's recent agreement with Lynne Franks OBE to produce women's beauty and well-being products infused with CBD utilizing the Company's proprietary formulation.
"We think there is a lot of potential in the UK for CBD infused products. It's a high growth industry here in the States, but it's more virgin, for lack of a better term, in the UK and Europe. We see as much, if not greater opportunities in the UK and Europe, due to lack of market penetration and consumer education. We think Lynne is a great person to get on the airwaves, as well as her columns, to educate consumers about the benefits of CBD as well as to promote our products we're producing with her."
Ryan also expressed that while their partnership with Lynne will be focused on the beauty and wellness segment, the company also plans to bring their line of CBD infused water to the UK in the coming months.
When asked about the company's other recent news, Ryan mentioned their recent deal with LinkResPet, a subsidiary of Link Reservations Inc. (OTC: LRSV), a company providing cannabidiol-based (CBD) products specifically for pets, to create a new CBD beverage aimed for pets. The Joint Venture (JV) plans to launch a new LinkResPet product beverage "powered by" LALPINA CBD by the end of the year.
Ryan expressed that this string of recent deals and agreements is all for the company's goal of uplisting in 2020, even seeking strategic alternatives for the FashionCoinX platform and the THRD coin utility token, which the company has begun preliminary discussions on. These structures would maximize shareholder value for the assets.
To find out more information on American Premium Water Corp and their LALPINA CBD Infused Beverages, visit their website at https://lalpinahydrocbd.com/.
Read the full article at https://www.investorideas.com/news/2019/cannabis-potcasts/06060OTCHIPH-RyanFishoff.asp
$CETX @Cemtrex Announces Final Court Approval of the Settlements in the Securities Class Action & Shareholder Derivative Lawsuits
LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--
Cemtrex Inc. (Nasdaq: CETX, CETXP, CETXW), a leading global technology company, today announced that the court has approved the previously announced settlements in the alleged securities class action lawsuit and related shareholder derivative litigations, filed in the Eastern District of New York and New York state court.
Under the class action settlement, the Company specifically denies any liability or that it has engaged in any wrongdoing. On behalf of the defendants, the Company’s insurer will pay $625,000 to the class of plaintiffs to resolve all claims asserted or could have been asserted in the litigation.
Under the derivative litigation settlement, the Company and the directors and officers of the Company named as defendants also deny any liability or wrongdoing in connection with the allegations contained in the lawsuit. The terms of the settlement require the Company to implement certain corporate governance changes and modify certain governance practices, and the Company’s insurer will pay $100,000 to the plaintiffs’ counsel. Like the class action settlement, the derivative litigation settlement resolves all claims that were or could have been asserted in the litigations.
“We are pleased to finally have the court approval of our settlement, and clear this cloud that has been hanging over us for the past two years,” said Saagar Govil, Cemtrex’s Chief Executive Officer, “This settlement has concluded these lawsuits expeditiously and further avoids interference on operations, which we believe is beneficial to the Company and its shareholders,” continued Mr. Govil.
The full settlement terms and all other filings in the class action litigation can be found under the case caption: Cullinan v. Cemtrex, Inc. et al., Case No. 2:17-cv-01067-JFB-AYS (E.D.N.Y.); the full settlement terms and all other filings in the derivative litigations are available under the following captions: Desmond-Newman v. Govil, et al., Case No. 2:18-cv-03992 (E.D.N.Y.), and Alami v. Govil, et al., No. 606635/2017 (N.Y. Sup. Ct., Suffolk County).
The Company is represented by Doug Greene, a nationally prominent securities litigation attorney, of the law firm of BakerHostetler.
About Cemtrex
Cemtrex, Inc. (CETX) is a diversified technology company that's driving innovation in a wide range of sectors, including smart technology, virtual and augmented realities, advanced electronic systems, industrial solutions, and intelligent security systems.
www.cemtrex.com
https://finance.yahoo.com/news/cemtrex-announces-final-court-approval-123000861.html
$NGTF Technical chart view
https://www.barchart.com/stocks/quotes/NGTF/technical-chart
$RGBP Just getting started again Support/Resistance Levels Price Key Turning Points
https://www.barchart.com/stocks/quotes/RGBP/cheat-sheet
$RGBP Fast Forwarding Checkpoint Medicine
Striving to improve the quality of life by introducing the latest in medical technology for treating cancer and autoimmunity
https://www.regenbiopharmainc.com/
$OZSC Ozop Surgical completes initial testing of its adjustable ALIF interbody spinal implant
Ozop Surgical Corp. (OTCMKTS:OZSC) announced Monday it has completed initial testing of its adjustable ALIF interbody spinal implant.
The Florida-based company began development of the ALIF implant, which is short for enhanced expandable anterior lumbar interbody fusion, in 2018.
The ALIF implant allows the surgeon to expand it after insertion into a disc space, reducing operating times while providing a cost savings for the hospital.
READ: Ozop rises as company gives vision for minimally invasive spinal surgery
CEO Michael Chermak said the company is encouraged by the initial-testing results and has “incorporated several improvements into our next design.”
Once the testing is completed and a final designated accepted, Ozop plans to submit the final design to the US Food and Drug Administration within the next two years.
“Developing an infinitely adjustable ALIF implant is a challenging design goal but the end outcome will allow the surgeon to ensure segmental stability and restore sagittal balance,” Chermak said. “We look forward to completing testing for FDA submission in the near future and hope to have our approval by the end of the year."
http://tinyurl.com/y6eqhlnu via @proactive_NA @OzopSurgical